TNFSF13B and B-cell non-Hodgkin lymphoma: Our functional assay showed that the three sdAbs could, in a dose dependent manner, inhibit BAFF-induced B-cell lymphoma cell proliferation and anti-BAFF64 sdAb, which had a higher affinity and was the most potent in inhibiting tumor cell proliferation.